Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × brexucabtagene autoleucel × 90 days × Clear all

Phase

Status

Recruiting 3 Terminated 1 Enrolling by invitation 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Mantle-Cell 1

Interventions

pembrolizumab 69 Nivolumab 40 Cyclophosphamide 38 Cisplatin 36 Carboplatin 31 Paclitaxel 28 Radiotherapy 23 Gemcitabine 23 Dexamethasone 21 fludarabine 19 Ipilimumab 19 Blood Specimen Collection 19 Cetuximab 18 atezolizumab 17 Doxorubicin 17 Surveys and Questionnaires 16 Standard of Care 16 Docetaxel 16 Prednisone 15 Fluorouracil 15 lenvatinib 14 Trastuzumab 14 Lenalidomide 14 Irinotecan 14 regorafenib 13 Pemetrexed 13 Oxaliplatin 13 Etoposide 13 Cytarabine 13 Rituximab 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02601313 2026-03-18

ZUMA-2

Gilead Sciences

Phase 2 Completed

105 enrolled 33 charts 2 FDA

Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡